Literature DB >> 20425058

Relationship of coronary angiographic findings to choice of antidiabetic medication.

Stuart W Zarich1.   

Abstract

Year:  2010        PMID： 20425058     DOI： 10.1007/s11892-009-0086-6

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  10 in total

1.  Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort.

Authors:  M M Graham; P D Faris; W A Ghali; P D Galbraith; C M Norris; J T Badry; L B Mitchell; M J Curtis; M L Knudtson
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

2.  Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.

Authors:  Gautham Ravipati; Wilbert S Aronow; Chul Ahn; Kumbar Sujata; Leonardo N Saulle; Venu Channamsetty; Melvin B Weiss
Journal:  Am J Ther       Date:  2006 Sep-Oct       Impact factor: 2.688

3.  Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.

Authors:  Theodore Mazzone; Peter M Meyer; Steven B Feinstein; Michael H Davidson; George T Kondos; Ralph B D'Agostino; Alfonso Perez; Jean-Claude Provost; Steven M Haffner
Journal:  JAMA       Date:  2006-11-13       Impact factor: 56.272

4.  Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.

Authors:  P D Home; S J Pocock; H Beck-Nielsen; R Gomis; M Hanefeld; H Dargie; M Komajda; J Gubb; N Biswas; N P Jones
Journal:  Diabetologia       Date:  2005-07-16       Impact factor: 10.122

5.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

6.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

7.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

8.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

9.  Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.

Authors:  Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Richard Nesto; Stuart Kupfer; Alfonso Perez; Horacio Jure; Robert De Larochellière; Cezar S Staniloae; Kreton Mavromatis; Jacqueline Saw; Bo Hu; A Michael Lincoff; E Murat Tuzcu
Journal:  JAMA       Date:  2008-03-31       Impact factor: 56.272

10.  Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients.

Authors:  R Kornowski; G S Mintz; A J Lansky; M K Hong; K M Kent; A D Pichard; L F Satler; J J Popma; T A Bucher; M B Leon
Journal:  Am J Cardiol       Date:  1998-06-01       Impact factor: 2.778
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.